Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRL

Charles River Laboratories International Inc

May 01 • 04:00PM ET

165.78

-1.19 -0.71 %

Healthcare • Diagnostics & Research • USA • Mid • NYSE

Peers: IQV LDOS MEDP CVS PFE ILMN BMY LH MRK

| Held by: VTI VOO VB RSP VBR IVV SPY IBB XLV DFAT

Scroll to Statements

Index	S&P 500	P/E	-	EPS (ttm)	-2.96	Insider Own	1.00%	Shs Outstand	49.22M	Perf Week	-2.37%
Market Cap	8.18B	Forward P/E	13.61	EPS next Y	12.18	Insider Trans	-0.08%	Shs Float	48.85M	Perf Month	-5.21%
Enterprise Value	10.64B	PEG	1.51	EPS next Q	1.94	Inst Own	107.85%	Short Float	9.55%	Perf Quarter	-21.24%
Income	-144.34M	P/S	2.04	EPS this Y	7.78%	Inst Trans	3.35%	Short Ratio	4.60	Perf Half Y	-7.98%
Sales	4.02B	P/B	2.58	EPS next Y	9.91%	ROA	-1.97%	Short Interest	4.67M	Perf YTD	-16.89%
Book/sh	64.30	P/C	38.15	EPS next 5Y	9.03%	ROE	-4.36%	52W High	228.88 -27.57%	Perf Year	41.83%
Cash/sh	4.35	P/FCF	15.78	EPS past 3/5Y	- -	ROIC	-2.52%	52W Low	113.89 45.57%	Perf 3Y	-12.79%
Dividend Est.	-	EV/EBITDA	11.77	Sales past 3/5Y	0.33% 6.55%	Gross Margin	30.52%	Volatility	3.30% 3.96%	Perf 5Y	-50.13%
Dividend TTM	-	EV/Sales	2.65	EPS Y/Y TTM	-1143.24%	Oper. Margin	12.48%	ATR (14)	7.15	Perf 10Y	109.13%
Dividend Ex-Date	-	Quick Ratio	1.02	Sales Y/Y TTM	-0.85%	Profit Margin	-3.59%	RSI (14)	43.49	Recom	1.89
Dividend Gr. 3/5Y	- -	Current Ratio	1.29	EPS Q/Q	-33.22%	SMA20	-4.96%	Beta	1.45	Target Price	203.93
Payout	-	Debt/Eq	0.83	Sales Q/Q	-0.83%	SMA50	-2.22%	Rel Volume	0.66	Prev Close	166.97
Employees	19700	LT Debt/Eq	0.81	Earnings	May 07 BMO	SMA200	-5.78%	Avg Volume	1.02M	Price	165.78
IPO	Jun 23, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.87% 0.73%	Trades		Volume	668,874	Change	-0.71%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)